Đang chuẩn bị liên kết để tải về tài liệu:
Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Breast cancer is the most common invasive cancer among women. Currently, there are only a few models used for therapy selection, and they are often poor predictors of therapeutic response or take months to set up and assay. | Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform

TÀI LIỆU LIÊN QUAN

Virologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda

PDXGEM: Patient-derived tumor xenograftbased gene expression model for predicting clinical response to anticancer therapy in cancer patients

Intraoperative radiation therapy induces immune response activity after pancreatic surgery

Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data

Response biomarkers: Re-envisioning the approach to tailoring drug therapy for cancer

The efficiency of 18F-FDG-PET/CT in the assessment of tumor response to preoperative chemoradiation therapy for locally recurrent rectal cancer

An agent-based model of prostate Cancer bone metastasis progression and response to Radium223

MRI in predicting the response of gastrointestinal stromal tumor to targeted therapy: A patient-based multi-parameter study

Radiographic response to neoadjuvant therapy and its impact on scope of surgery and prognosis in stage IIB/III soft tissue sarcomas

Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.